RE: Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis (Azola et al. JGIM)

• by Jason D. Goldman, Jeffrey N. Martin

• October 13, 2026

FDA approves pritelivir for refractory HSV lesions

In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.

• by Teraya Smith

• October 9, 2026

• 2 min

Unsupervised clustering to classify patients with candidemia in intensive care: algorithmic tautology or the generation of highly anticipated new data?

• by Florian Reizine, Renaud Prével, Jean-Pierre Gangneux

• October 15, 2026

From Measurement Failure to Privacy Infrastructure: Reframing Contact Tracing Governance for the Next Pandemic

• by Yusaku Fujii

• October 5, 2026